Pipeline & Products:

Sorbent’s robust CLP Platform offers an array of non-absorbed polymers that are chemically and bio-designed to selectively contribute or sequester targeted ions and fluid to deliver the prescribed therapeutic action in the gastro intestinal tract.


Congestive Heart Failure (CHF) with Chronic Kidney Disease
CLP 1001
(Removes Potassium, Sodium & Fluid)

Chronic Kidney Disease/End Stage Renal Disease
CLP 1004
(Removes Potassium)

Congestive Heart Failure (Fluid Overload)
CLP 1003
(Removes Sodium & Fluid)

**  The FDA has designated the Investigation of Cross-Linked Polyelectrolyte (CLP) for patients undergoing Hemodialysis or in Congestive Heart Failure to Fast Track
 
   
©2012 Sorbent Therapeutics, Inc.